Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIIB | INSM | RPRX | ||
| Company | Biogen Inc | Insmed Inc | Royalty Pharma Plc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 194.07 | 149.77 | 44.08 | ||
| High | 195.72 | 151.17 | 44.26 | ||
| Low | 188.74 | 147.63 | 43.63 | ||
| Latest | 188.99 | 148.55 | 44.21 | ||
| Change | -4.82 | -0.99 | +0.16 | ||
| % Change | -2.49% | -0.66% | +0.36% | ||
| Volume | 1,836,200 | 2,259,300 | 3,148,700 | ||
| 20-Day Average Volume | 1,738,065 | 2,461,840 | 4,001,770 | ||
| Previous Close | 193.81 | 149.54 | 44.05 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 177.64 | 156.99 | 41.47 | ||
| 20-Day Raw Stochastic | 68.08% | 8.94% | 88.21% | ||
| 20-Day Relative Strength | 58.14 | 35.97 | 70.05 | ||
| Weighted Alpha | +46.55 | +57.48 | +41.41 | ||
| Today's Opinion | 88% Buy | 8% Sell | 100% Buy | ||
| Previous Opinion | 88% Buy | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.92% since 02/03/26 | -5.48% since 02/03/26 | +2.89% since 02/03/26 | ||
| Low | 177.10 on 02/04/26 | 146.40 on 02/09/26 | 43.02 on 02/04/26 | ||
| High | 202.41 on 02/06/26 | 157.90 on 02/04/26 | 44.92 on 02/06/26 | ||
| 1-Month | |||||
| %Chg | +0.73% since 01/09/26 | -15.58% since 01/09/26 | +10.06% since 01/09/26 | ||
| Low | 160.36 on 01/20/26 | 146.40 on 02/09/26 | 38.86 on 01/20/26 | ||
| High | 202.41 on 02/06/26 | 175.12 on 01/12/26 | 44.92 on 02/06/26 | ||
| 3-Month | |||||
| %Chg | +20.95% since 11/10/25 | -22.60% since 11/10/25 | +14.71% since 11/10/25 | ||
| Low | 154.20 on 11/11/25 | 146.40 on 02/09/26 | 37.31 on 11/24/25 | ||
| High | 202.41 on 02/06/26 | 212.75 on 12/02/25 | 44.92 on 02/06/26 | ||
| 6-Month | |||||
| %Chg | +44.63% since 08/08/25 | +35.60% since 08/08/25 | +17.64% since 08/08/25 | ||
| Low | 127.71 on 08/11/25 | 109.18 on 08/11/25 | 34.08 on 09/08/25 | ||
| High | 202.41 on 02/06/26 | 212.75 on 12/02/25 | 44.92 on 02/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 27,735,984 | 31,681,704 | 25,519,690 | ||
| Shares Outstanding, K | 146,759 | 213,273 | 577,238 | ||
| Annual Sales | 9,890,600,000 | 363,710,000 | 2,263,580,000 | ||
| Annual Net Income | 1,292,900,000 | -913,770,000 | 858,980,000 | ||
| Last Quarter Sales | 2,279,400,000 | 142,340,000 | 609,290,000 | ||
| Last Quarter Net Income | -48,900,000 | -370,020,000 | 288,220,000 | ||
| 60-Month Beta | 0.16 | 1.11 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.99 on 02/06/26 | -1.75 on 10/30/25 | 1.17 on 11/05/25 | ||
| Latest Earnings Date | 05/07/26 | 02/19/26 | 02/11/26 | ||
| Most Recent Dividend | N/A | N/A | 0.220 on 11/14/25 | ||
| Next Ex-Dividends Date | N/A | N/A | 02/20/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 12.68 | 0.00 | 9.75 | ||